Marie Payton
Chief Tech/Sci/R&D Officer chez LOGICBIO THERAPEUTICS, INC.
Profil
Marie Payton is currently the VP-Clinical Development Operations at LogicBio Therapeutics, Inc. She previously worked as the Senior Director-Clinical Operations at Aileron Therapeutics, Inc. She received an undergraduate degree from the University of Massachusetts and an MBA from F.W.
Olin Graduate School of Business.
Postes actifs de Marie Payton
| Sociétés | Poste | Début |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2019 |
Anciens postes connus de Marie Payton
| Sociétés | Poste | Fin |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Chief Operating Officer | - |
Formation de Marie Payton
| University of Massachusetts | Undergraduate Degree |
| F.W. Olin Graduate School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
